LEE SUNG (EVP, Chief Financial Officer) sold 27.4% of their position (23.91K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $1.84M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001061983-26-000049
Officer· EVP, Chief Financial Officer
Since Apr 2024
-23.91K
Net shares
Net seller
$1.84M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
23.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.91K
Price / share
$76.87
Trade value
$1.84M
% of position
27.4%
5/5/2026
87.13K→63.22K
Total
Net shares
−23.91K
Net value
-$1.84M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | S · Sale | −23.91K | $76.87 | $1.84M | 27.4% | 87.13K | 63.22K |
| Total | −23.91K | -$1.84M | ||||||
Derivative Transactions0
No derivative transactions reported